当前位置:首页 - 行情中心 - 昆药集团(600422) - 财务分析

昆药集团

(600422)

  

流通市值:66.24亿  总市值:66.24亿
流通股本:7.57亿   总股本:7.57亿

昆药集团(600422)财务分析

利润表
报告期2026-09-302026-06-302026-03-312025-12-31
营业总收入2,722,378,839.141,643,045,313.73836,158,258.46,575,214,133.55
营业总成本3,040,478,562.51,961,200,668.751,005,316,275.736,335,560,770.88
其他经营收益
营业利润-407,355,670.39-390,851,897.35-134,001,212.92448,507,950.06
利润总额-413,195,629.26-395,676,831.18-138,290,887.81473,557,838.67
净利润-363,451,714.75-369,694,713.72-144,847,651.79419,052,861.68
每股收益
其他综合收益-1,237,975.28-1,485,007.07-1,449,310.54-12,037,693.62
综合收益总额-364,689,690.03-371,179,720.79-146,296,962.33407,015,168.06
资产负债表
报告期2026-09-302026-06-302026-03-312025-12-31
流动资产:
流动资产合计6,559,428,321.986,920,155,558.047,123,806,677.487,723,739,881.55
非流动资产:
非流动资产合计3,964,838,438.414,060,157,621.224,091,596,597.774,049,824,526.9
资产总计10,524,266,760.3910,980,313,179.2611,215,403,275.2511,773,564,408.45
流动负债:
流动负债合计3,113,010,190.763,552,745,860.523,411,923,430.743,825,689,164.7
非流动负债:
非流动负债合计967,352,493.24990,153,273.111,005,932,579.481,006,470,657.09
负债合计4,080,362,6844,542,899,133.634,417,856,010.224,832,159,821.79
所有者权益(或股东权益):
归属于母公司股东权益合计4,862,322,547.84,864,074,777.365,221,546,495.855,362,259,636.54
股东权益合计6,443,904,076.396,437,414,045.636,797,547,265.036,941,404,586.66
负债和股东权益合计10,524,266,760.3910,980,313,179.2611,215,403,275.2511,773,564,408.45
现金流量表
报告期2026-09-302026-06-302026-03-312025-12-31
经营活动产生的现金流量:
经营活动现金流入小计3,263,122,422.782,238,582,247.04890,320,952.137,500,547,034.08
经营活动现金流出小计3,940,072,617.992,752,609,623.651,504,009,741.857,211,310,931.28
经营活动产生的现金流量净额-676,950,195.21-514,027,376.61-613,688,789.72289,236,102.8
投资活动产生的现金流量:
投资活动现金流入小计2,461,201,104.571,656,167,598.06813,042,541.725,345,256,380.8
投资活动现金流出小计2,100,856,347.021,413,244,714.36843,294,992.015,982,259,480.97
投资活动产生的现金流量净额360,344,757.55242,922,883.7-30,252,450.29-637,003,100.17
筹资活动产生的现金流量:
筹资活动现金流入小计662,905,234.86582,692,436.29241,761,560.451,756,208,570.61
筹资活动现金流出小计1,104,372,162.34761,209,078.06337,609,378.232,410,844,094.49
筹资活动产生的现金流量净额-441,466,927.48-178,516,641.77-95,847,817.78-654,635,523.88
汇率变动对现金及现金等价物的影响-3,615,210.68-2,931,460.87-1,835,325.48-534,546.4
现金及现金等价物净增加额-761,687,575.82-452,552,595.55-741,624,383.27-1,002,937,067.65
期末现金及现金等价物余额369,299,768.3678,434,748.57389,362,960.851,130,987,344.12
补充资料:
现金及现金等价物的净增加额--452,552,595.55--1,002,937,067.65
最新报告期:2026-10-29
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华创证券郑辰,高初蕾-0.480.180.402026-10-29
国金证券王奔奔,甘坛焕-0.400.130.352026-10-25
华泰证券代雯,唐庆雷,张云逸-0.060.400.552026-08-23
TOP↑